We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s 2011 Budget Would Increase Reviewers, Add Generic-Drug Plant Inspectors
FDA’s 2011 Budget Would Increase Reviewers, Add Generic-Drug Plant Inspectors
February 16, 2010
The FDA’s $4.03 billion budget request for fiscal 2011 would increase its capacity to review ANDAs by hiring six new inspectors to conduct inspections of generic-drug manufacturing facilities and four new staff to conduct reviews.